Detalhe da pesquisa
1.
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
JAMA
; 325(15): 1513-1523, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33877274
2.
Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP.
Pediatr Blood Cancer
; 59(5): 939-40, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22492703
3.
Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative.
Front Genet
; 13: 921432, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36092883
4.
Stepping Systematically Forward Toward Health Equity in Sickle Cell Disease.
JAMA Pediatr
; 178(3): 225, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190149
5.
Barriers to Pediatric Sickle Cell Disease Guideline Recommendations.
Glob Pediatr Health
; 6: 2333794X19847026, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106244
6.
Research in athletes with sickle cell trait: just do it.
J Appl Physiol (1985)
; 112(9): 1433, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22362400